Repligen Corp (RGEN)

Repligen Corp Aktie (RGEN) Neueste Nachrichten

Oct 30, 2026

Form 8K Repligen Corporation For: 30 October By Investing.com - Investing.com UK

Oct 30, 2026

Oct 28, 2026

Repligen Corporation (RGEN) Surges on Revenue Beat and Raised Full-Year Organic Outlook - Yahoo Finance

Oct 28, 2026

Oct 28, 2026

Repligen Corporation (RGEN) Benefits From Biotech Momentum and Strong Earnings - Yahoo Finance

Oct 28, 2026

Oct 28, 2026

Canaccord reiterates Hold on Repligen stock after Q3 beat By Investing.com - Investing.com Canada

Oct 28, 2026

Oct 27, 2026

Repligen Posts Record Q3 Revenue, Narrows 2026 Organic Growth Outlook - TradingKey

Oct 27, 2026

Oct 27, 2026

Repligen (RGEN) Reports Record Q3 Revenue, Boosts 2026 Guidance Amid Acquisition - GuruFocus

Oct 27, 2026

Oct 27, 2026

Repligen Corp (RGEN) Q3 2026 Earnings Call Highlights: Record Re - GuruFocus

Oct 27, 2026

Oct 27, 2026

Repligen Corp (RGEN) Q3 2026 Earnings Call Highlights: Record Re - GuruFocus

Oct 27, 2026

Oct 27, 2026

Repligen Corporation Q3 2026 Earnings Call Summary - Yahoo Finance

Oct 27, 2026

Oct 27, 2026

Conestoga Small Cap Composite Q3 2026 Portfolio Activity - Seeking Alpha

Oct 27, 2026

Oct 27, 2026

Repligen Q3 2026 slides: record revenue, raised guidance, margins expand - Investing.com

Oct 27, 2026

Oct 27, 2026

Earnings call transcript: Repligen tops Q3 2026 forecasts but shares slip - Investing.com

Oct 27, 2026

Oct 27, 2026

Repligen Corp Reports Q3 2026 Results: $209.3 Million Revenue, G - GuruFocus

Oct 27, 2026

Oct 27, 2026

Repligen Q3 2026 Earnings Call Transcript - Benzinga

Oct 27, 2026

Oct 27, 2026

Repligen Q3 2026 Earnings Call Transcript - Benzinga

Oct 27, 2026

Oct 27, 2026

Q3 2026 Repligen Corporation Earnings Call Transcript - GuruFocus

Oct 27, 2026

Oct 27, 2026

Repligen (NASDAQ:RGEN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations - Yahoo Finance

Oct 27, 2026

Oct 27, 2026

Form 8K Repligen Corporation For: 27 October By Investing.com - Investing.com Canada

Oct 27, 2026

Oct 27, 2026

Repligen Reports Q3 Revenue Growth, Raises 2026 Guidance - TradingView

Oct 27, 2026

Oct 27, 2026

Repligen earnings beat by $0.07, revenue topped estimates - Investing.com

Oct 27, 2026

Oct 27, 2026

Repligen: Q3 Earnings Snapshot - Yahoo Finance

Oct 27, 2026

Oct 26, 2026

symbol__ Stock Quote Price and Forecast - CNN

Oct 26, 2026

Oct 26, 2026

Repligen earnings in focus as bioprocessing growth accelerates - Investing.com

Oct 26, 2026

Oct 20, 2026

Repligen Corporation Bonds — Corporate Bond Rates - TradingView

Oct 20, 2026

Oct 20, 2026

Las ETF que invierten en acciones de Repligen Corporation - TradingView

Oct 20, 2026

Oct 17, 2026

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

Oct 17, 2026

Oct 15, 2026

Repligen Corp (RGEN) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 85/100 - GuruFocus

Oct 15, 2026

Oct 13, 2026

Repligen to Report Third Quarter 2026 Financial Results - Yahoo Finance

Oct 13, 2026

Oct 12, 2026

Form 144 REPLIGEN CORP For: 12 October By Investing.com - Investing.com Canada

Oct 12, 2026

Oct 12, 2026

RGEN5964422 Bond Profile: Coupon and Redemption - TradingView

Oct 12, 2026

Oct 10, 2026

Repligen Corp (BSP:R2GE34) Stock Holders - Institutional & Insider Ownership - GuruFocus

Oct 10, 2026

Oct 09, 2026

Is It Too Late to Buy Repligen Corp (RGEN) After 6.1% Rally? GF Value Says Undervalued - GuruFocus

Oct 09, 2026

Oct 09, 2026

Repligen Corp (RGEN) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus

Oct 09, 2026

Oct 09, 2026

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

Oct 09, 2026

Oct 08, 2026

A 700-share stock grant joins options with a $174.86 exercise price for Repligen (RGEN)’s chief product officer. - Stock Titan

Oct 08, 2026

Oct 08, 2026

Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus

Oct 08, 2026

Oct 07, 2026

One holder reports no voting power in Repligen (RGEN), despite a 7.36M-share passive stake. - Stock Titan

Oct 07, 2026

Oct 07, 2026

Repligen CEO Olivier Loeillot sells $1.03m of company stock By Investing.com - Investing.com Nigeria

Oct 07, 2026

Oct 06, 2026

Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,535 Shares - GuruFocus

Oct 06, 2026

Oct 06, 2026

Repligen Corp (RGEN) Shares Fall 7.7% -- What GF Score of 85 Tel - GuruFocus

Oct 06, 2026

Oct 06, 2026

Repligen CEO Olivier Loeillot sells $1.03m of company stock - Investing.com

Oct 06, 2026

Oct 06, 2026

Repligen (RGEN) CEO sells shares at $190 and $178.75 under a preset trading plan. - Stock Titan

Oct 06, 2026

Oct 06, 2026

Repligen Closes BioLife Solutions Acquisition - Yahoo Finance

Oct 06, 2026

Oct 06, 2026

Repligen completes acquisition of BioLife Solutions - Investing.com

Oct 06, 2026

Oct 06, 2026

18 commercially approved therapies are supported by BioLife's cell-preserving media. Repligen completed the deal. - stocktitan.net

Oct 06, 2026

Oct 06, 2026

Repligen Completes Acquisition of BioLife Solutions - Yahoo Finance

Oct 06, 2026

Oct 06, 2026

Repligen Insider Sold Shares Worth $1,036,654, According to a Recent SEC Filing - Yahoo Finance

Oct 06, 2026

Oct 06, 2026

Form 144 REPLIGEN CORP For: 5 October By Investing.com - Investing.com South Africa

Oct 06, 2026

Oct 05, 2026

Repligen Corp (RGEN) Stock Up 4.3% but GF Value Says Overvalued -- GF Score: 85/100 - GuruFocus

Oct 05, 2026

Oct 05, 2026

Loeillot proposes selling 4,202 Repligen (RGEN) shares through Fidelity. - stocktitan.net

Oct 05, 2026